A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
Prevalence rate of diabetes mellitus worldwide and in Russian Federation is epidemic in its nature. Prospective studies have shown thatmaintenance of glycemic target reduces risk of late vascular complications. In turn, strict glycemic control requires modern approach tointensification of glucose lo...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/35253e7c4a53459592ef9b11416ba12a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:35253e7c4a53459592ef9b11416ba12a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:35253e7c4a53459592ef9b11416ba12a2021-11-14T09:00:17ZA1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before2072-03512072-037810.14341/2072-0351-5981https://doaj.org/article/35253e7c4a53459592ef9b11416ba12a2012-03-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5981https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Prevalence rate of diabetes mellitus worldwide and in Russian Federation is epidemic in its nature. Prospective studies have shown thatmaintenance of glycemic target reduces risk of late vascular complications. In turn, strict glycemic control requires modern approach tointensification of glucose lowering therapy. Randomized clinical trials prove capacity of modern insulin analogues to improve glycemiccontrol while decreasing risk of hypoglycemic events and weight gain. Current paper presents initial data on 9342 patients, participatedin multicenter prospective 52-week observational study A1chieve, conducted in order to assess efficiency and safety of treatment withinsulin analogues Levemir?, NovoMix? and NovoRapid? (Novo Nordisk) in daily management of patients with type 2 diabetes mellitus,who never received that treatment before.Marina Vladimirovna ShestakovaEndocrinology Research Centrearticlediabetes mellitus type 2observational study a1chieveinsulin analoguesNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 1, Pp 63-70 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
diabetes mellitus type 2 observational study a1chieve insulin analogues Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
diabetes mellitus type 2 observational study a1chieve insulin analogues Nutritional diseases. Deficiency diseases RC620-627 Marina Vladimirovna Shestakova A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| description |
Prevalence rate of diabetes mellitus worldwide and in Russian Federation is epidemic in its nature. Prospective studies have shown thatmaintenance of glycemic target reduces risk of late vascular complications. In turn, strict glycemic control requires modern approach tointensification of glucose lowering therapy. Randomized clinical trials prove capacity of modern insulin analogues to improve glycemiccontrol while decreasing risk of hypoglycemic events and weight gain. Current paper presents initial data on 9342 patients, participatedin multicenter prospective 52-week observational study A1chieve, conducted in order to assess efficiency and safety of treatment withinsulin analogues Levemir?, NovoMix? and NovoRapid? (Novo Nordisk) in daily management of patients with type 2 diabetes mellitus,who never received that treatment before. |
| format |
article |
| author |
Marina Vladimirovna Shestakova |
| author_facet |
Marina Vladimirovna Shestakova |
| author_sort |
Marina Vladimirovna Shestakova |
| title |
A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_short |
A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_full |
A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_fullStr |
A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_full_unstemmed |
A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_sort |
a1chieve program in russian federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| publisher |
Endocrinology Research Centre |
| publishDate |
2012 |
| url |
https://doaj.org/article/35253e7c4a53459592ef9b11416ba12a |
| work_keys_str_mv |
AT marinavladimirovnashestakova a1chieveprograminrussianfederationamulticenterprospectiveobservationalstudyofinsulinanaloguetreatmentefficiencyandsafetyindailymanagementofpatientswithtype2diabetesmellituswhostartandintensifyinsulintreatmenthavingneverreceiveditbefore |
| _version_ |
1718429575920222208 |